These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 3937060)

  • 41. DL-Threo-3,4-dihydroxyphenylserine does not exert a pressor effect in orthostatic hypotension.
    Hoeldtke RD; Cilmi KM; Mattis-Graves K
    Clin Pharmacol Ther; 1984 Sep; 36(3):302-6. PubMed ID: 6432398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) on catecholamine levels in plasma and cerebrospinal fluid (CSF) in anesthetized rats.
    Ishikawa Y; Kato Y; Murakami Y; Inoue T; Koshiyama H; Imura H
    Proc Soc Exp Biol Med; 1987 Feb; 184(2):197-200. PubMed ID: 3101067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Attenuation of haloperidol-induced catalepsy by noradrenaline and L-threo-DOPS.
    Verhagen-Kamerbeek WD; Hazemeijer I; Korf J; Lakke JP
    J Neural Transm Park Dis Dement Sect; 1993; 6(1):17-26. PubMed ID: 8216760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, inhibits dopamine release and metabolism in the rat striatum in vivo.
    Mizoguchi K; Tanaka M; Yokoo H; Yoshida M; Tsuda A
    Experientia; 1992 Dec; 48(11-12):1133-4. PubMed ID: 1473578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues.
    Soares-da-Silva P
    Gen Pharmacol; 1993 Jan; 24(1):75-81. PubMed ID: 8482506
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of norepinephrine in feeding behavior.
    Rossi J; Zolovick AJ; Davies RF; Panksepp J
    Neurosci Biobehav Rev; 1982; 6(2):195-204. PubMed ID: 6285235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effects of L-threo-3,4-dihydroxyphenylserine on the total norepinephrine and dopamine concentrations in the cerebrospinal fluid and freezing gait in parkinsonian patients.
    Tohgi H; Abe T; Takahashi S
    J Neural Transm Park Dis Dement Sect; 1993; 5(1):27-34. PubMed ID: 8439390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The involvement of noradrenaline, 5-hydroxytryptamine and acetylcholine in imipramine-induced seizures in mice.
    Amabeoku GJ
    Experientia; 1993 Oct; 49(10):859-64. PubMed ID: 8224101
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of L-threo DOPS in the control of Na-K ATPase activity of the marginal cells in the stria vascularis of reserpinized guinea pigs.
    Kanoh N; Nomura J
    Acta Otolaryngol Suppl; 1995; 520 Pt 2():381-3. PubMed ID: 8749167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Depressor action of L-threo-dihydroxyphenylserine in the rat nucleus tractus solitarii.
    Miyamae T; Yue JL; Goshima Y; Misu Y
    Eur J Pharmacol; 1996 Apr; 300(1-2):105-8. PubMed ID: 8741173
    [TBL] [Abstract][Full Text] [Related]  

  • 51. DL-3,4-threo-DOPS in Parkinson's disease: effects on orthostatic hypotension and dizziness.
    Birkmayer W; Birkmayer G; Lechner H; Riederer P
    J Neural Transm; 1983; 58(3-4):305-13. PubMed ID: 6420517
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy.
    Suzuki T; Higa S; Sakoda S; Ueji M; Hayashi A; Takaba Y; Nakajima A
    Eur J Clin Pharmacol; 1982; 23(5):463-8. PubMed ID: 6818040
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease.
    Yamamoto M; Ogawa N; Ujike H
    J Neurol Sci; 1986 Mar; 73(1):39-44. PubMed ID: 3084714
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of hypotensive and brain catecholamine depleting effects by erythro- and threo-alpha-methyl DOPS.
    Castellucci A; Bonacchi G; Bacciarelli C; Boni P
    Arzneimittelforschung; 1979; 29(1):27-31. PubMed ID: 582113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of L-threo-dihydroxyphenylserine on spinal reflexes and decerebrate rigidity in rats.
    Ono H; Tanabe M; Nakamura T; Nagano N; Fukuda H
    Gen Pharmacol; 1988; 19(3):369-72. PubMed ID: 3138156
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mass spectrometric measurements of norepinephrine synthesis in man from infusion of stable isotope-labelled L-threo-3,4-dihydroxyphenylserine.
    Suzuki T; Sakoda S; Ueji M; Kishimoto S
    Life Sci; 1985 Feb; 36(5):435-42. PubMed ID: 3918223
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in spinal trigeminal nucleus.
    Sasa M; Ohno Y; Nabatame H; Yoshimura N; Takaori S
    Brain Res; 1987 Sep; 420(1):157-61. PubMed ID: 3119149
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy.
    Suzuki T; Higa S; Tsuge I; Sakoda S; Hayashi A; Yamamura Y; Takaba Y; Nakajima A
    Eur J Clin Pharmacol; 1980 Jun; 17(6):429-35. PubMed ID: 6772451
    [TBL] [Abstract][Full Text] [Related]  

  • 59. d,l-threo-3,4-dihydroxyphenylserine restores sympathetic control and cures orthostatic hypotension in dopamine beta-hydroxylase deficiency.
    Man in 't Veld AJ; Boomsma F; van den Meiracker AH; Julien C; Lenders J; Schalekamp MA
    J Hypertens Suppl; 1988 Dec; 6(4):S547-9. PubMed ID: 3149290
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of orthostatic hypotension in Shy-Drager syndrome with DL-threo-3,4-dihydroxyphenylserine: a case report.
    Sakoda S; Suzuki T; Higa S; Ueji M; Kishimoto S; Matsumoto M; Yoneda S
    Eur Neurol; 1985; 24(5):330-4. PubMed ID: 3932074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.